- Home
- JEF vs NBIX Comparison
JEF vs NBIX Comparison
Compare JEF & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEF
- NBIX
- Stock Information
- Founded
- JEF 1968
- NBIX 1992
- Country
- JEF United States
- NBIX United States
- Employees
- JEF N/A
- NBIX N/A
- Industry
- JEF Investment Bankers/Brokers/Service
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JEF Finance
- NBIX Health Care
- Exchange
- JEF Nasdaq
- NBIX Nasdaq
- Market Cap
- JEF 11.0B
- NBIX 12.0B
- IPO Year
- JEF N/A
- NBIX 1996
- Fundamental
- Price
- JEF $48.58
- NBIX $123.02
- Analyst Decision
- JEF Buy
- NBIX Strong Buy
- Analyst Count
- JEF 4
- NBIX 20
- Target Price
- JEF $56.67
- NBIX $163.20
- AVG Volume (30 Days)
- JEF 1.3M
- NBIX 1.6M
- Earning Date
- JEF 06-25-2025
- NBIX 05-05-2025
- Dividend Yield
- JEF 3.29%
- NBIX N/A
- EPS Growth
- JEF 144.59
- NBIX N/A
- EPS
- JEF 2.90
- NBIX 2.96
- Revenue
- JEF $6,865,419,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- JEF N/A
- NBIX $15.99
- Revenue Next Year
- JEF $15.07
- NBIX $14.93
- P/E Ratio
- JEF $17.06
- NBIX $41.60
- Revenue Growth
- JEF 33.18
- NBIX 21.73
- 52 Week Low
- JEF $39.28
- NBIX $84.23
- 52 Week High
- JEF $82.68
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- JEF 45.47
- NBIX 62.85
- Support Level
- JEF $47.28
- NBIX $117.59
- Resistance Level
- JEF $50.09
- NBIX $125.63
- Average True Range (ATR)
- JEF 1.19
- NBIX 2.98
- MACD
- JEF -0.25
- NBIX -0.02
- Stochastic Oscillator
- JEF 16.65
- NBIX 72.90
About JEF Jefferies Financial Group Inc.
Jefferies Financial Group Inc is a full-service investment banking and capital markets firm. It has two reportable segments; Investment Banking and Capital Markets which is also the majority revenue generating segment, includes securities, commodities, corporate lending, futures and foreign exchange capital markets activities and its investment banking business, which provides underwriting and financial advisory services to clients across different sectors. The Asset Management reportable business segment provides alternative investment management services to investors in the U.S. and overseas and generates investment income from capital invested in and managed by it or its affiliated asset managers. Operates geographically in America, Europe and Middle East, Asia Pasific.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.